Biggest win for patients has likely been the continuation of Medicare drug price negotiati ...

After years of pretending, it seems Trump and Republicans have grown confident enough to flatly admit they don't give a rip ...

Medicare, long banned from covering weight loss treatments, will now allow beneficiaries to get a GLP-1 prescription for $50 ...

Here are 10 Medicare changes in 2026, including provisions of the IRA, with a few tweaks, that will remain in effect after ...

Price controls, even when discussed in “America First” wording, could distort markets, chill innovation, and ultimately fail ...

An ASHP report projects that in 2026, overall drug spending will exceed $1 trillion for the first time—driven primarily by ...

Reps. Don Davis (D-N.C.) and Claudia Tenney (R-N.Y.) said Thursday the House is prepared to pass legislation supporting wider ...

Understand the historic reconfiguration of Part D and how the new out-of-pocket spending limit will transform your financial ...

OpenSecrets reports that 17 drug companies in TrumpRx boosted lobbying by 23% to over $130M in 2025, outpacing the broader ...

Re “The Biggest Cause of High Health Care Spending,” by Zack Cooper (Opinion guest essay, May 7): As a physician, a health ...

US to stop overpaying for drugs while protecting innovation through its MFN drug pricing framework: Shardul Nautiyal, Mumbai Tuesday, May 12, 2026, 08:00 Hrs [IST] The US will now ...